Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status
-
* Corresponding author: Tanja Fehm Tanja.fehm@t-online.de
Breast Cancer Research 2007, 9:R74 doi:10.1186/bcr1783
Accesses
- Last 30 days: 97 accesses
- Last 365 days: 1053 accesses
- All time: 6810 accesses